https://n.neurology.org/content/96/8/e1251#:~:text=A%20recent%20meta%2Danalysis%20of,of%201.2%2F100%2C000%2Fy.
you should read this study from Wales, it is another data point which estimates the incidence at 7.8 and prevalence at 75. As far as I understand it, this is very different from Invex's stated numbers, which work on an incidence * 4.3 years to determine prevalence. Whereas, this data from wales would show prevalence = 7.8 * 9.6 years, over double the amount of time with the disease. Could be due to climate or something in Wales, im not sure, but it isn't solely due to obesity
- Forums
- ASX - By Stock
- DCF Valuation Model for Invex Therapeutics
https://n.neurology.org/content/96/8/e1251#:~:text=A%20recent%20m...
-
-
- There are more pages in this discussion • 163 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IXC (ASX) to my watchlist
|
|||||
Last
6.0¢ |
Change
-0.007(10.5%) |
Mkt cap ! $4.509M |
Open | High | Low | Value | Volume |
6.0¢ | 6.0¢ | 6.0¢ | $3.264K | 54.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 600 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 600 | 0.060 |
1 | 15002 | 0.052 |
2 | 410000 | 0.051 |
1 | 200000 | 0.050 |
1 | 60001 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 20000 | 1 |
0.077 | 7950 | 1 |
0.078 | 20000 | 1 |
0.081 | 888 | 1 |
0.083 | 5724 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online